Cerebrolysin

⚠️ Structural Separation Notice

The Ageless Pep Academy is a clinical education property independent from any commerce operation. Any references in this profile to Ageless Peps product SKUs, pricing, or the agelesspeps.com domain are for completeness and transparency; they are not endorsements and do not form part of the clinical education content. Clinicians are responsible for independent verification of any product sourcing decision. The Academy's Medical Director provides editorial oversight only and does not endorse commercial products.

Quick Facts

• Full Name: Cerebrolysin (FPF-1070)
• Aliases: Cere, FPF-1070, EVER Neuro Pharma product
• Category: Neuroprotection / Neurogenesis / Dementia Treatment
• Type: Mixture of low-molecular-weight neurotrophic peptide fragments (derived from porcine brain protein hydrolysate)
• Molecular Weight: <10,000 Da (mixture of peptide fragments)
• Administration: Intramuscular (IM) / Intravenous (IV)
• Typical Dose: 5–10 mL/day IM or IV
• Duration: 10–20 day cycles, typically
• Status: Approved in several countries (Russia, China, EU); Research Only in USA/Canada
• WADA Status: Not listed

What It Does

Cerebrolysin is a standardized mixture of neuropeptide fragments that mimics the combined action of multiple neurotrophic factors — BDNF, NGF, CNTF, and GDNF — providing broad neuroprotective, neurogenic, and neurotrophic support. It is approved for stroke rehabilitation and dementia treatment in numerous countries. Active peptide fragments cross the blood-brain barrier and directly modulate neuronal survival, synaptic plasticity, and neurogenesis. The parent compound for the P21 neurogenic peptide fraction.

Mechanism of Action

1. Multi-neurotrophic factor mimicry: Active peptide fractions (including P21) mimic BDNF, NGF, CNTF, and GDNF → comprehensive neurotrophic support without requiring full-size protein administration
2. BDNF and NGF upregulation: Promotes endogenous synthesis of both factors in hippocampus and cortex
3. Neurogenesis: Stimulates hippocampal and cortical neural stem cell proliferation → measurable increases in hippocampal volume
4. Anti-excitotoxic protection: Reduces glutamate-mediated neuronal injury; stabilizes calcium homeostasis
5. Anti-apoptotic signaling: Activates PI3K/Akt and MAPK/ERK survival pathways
6. Synaptic plasticity: Enhances LTP (long-term potentiation) → improved memory consolidation
7. Amyloid and tau modulation: Reduces Aβ aggregation and tau hyperphosphorylation in preclinical Alzheimer's models

Ageless Peps Products

• APWS-Cerebrolysin-Vial — Cerebrolysin 60mg Vial, $25, wholesale only

Dosing Protocols

Standard Neurological Protocol

• Dose: 5–10 mL IM or IV
• Frequency: Once daily
• Duration: 10–20 consecutive days
• Rest: 1–3 months between courses
• IM: Inject undiluted into gluteal muscle
• IV: Dilute in 100–250 mL normal saline; infuse over 60–120 minutes
• Source: The Peptides Bible, manufacturer protocols, Auer et al.

Performance / Cognitive Protocol

• 5 mL IM daily × 10 days; repeat quarterly
• Stack with NSI-189 for additive neurogenesis

Stacks Well With

• RG3 + NSI-189 – advanced neurogenesis and neuroprotection stack
• Semax – BDNF + NGF multi-pathway cognitive stack
• Selank – anxiolytic and BDNF complement
• P21 – concentrated active peptide fraction of Cerebrolysin
• BPC-157 – systemic healing and neuroprotection synergy

Use Cases

• Stroke Recovery (post-stroke neurological recovery) — see Post-Stroke Recovery Protocol
• Dementia and Alzheimer's Disease management
• TBI Recovery (traumatic brain injury)
• Cognitive Enhancement (healthy aging, performance)
• Depression and treatment-resistant mood disorders
• Neurogenesis and neuroplasticity optimization
• Neuroprotection

Contraindications & Safety

• Active malignancy — neurotrophic growth factors; caution
• Epilepsy — seizure threshold may be affected; monitor
• Renal impairment — slow IV administration; monitor
• Porcine protein allergy — derived from pig brain; avoid in allergy
• IV administration — must be diluted properly; rapid IV push contraindicated
• Common side effects: Mild injection site reaction (IM), warmth/flushing during IV, dizziness; headache rare

Storage

• Ampules: Room temperature; protect from freezing and light; 3-year shelf life
• Once opened: Use immediately
• IV diluted solution: Use within 24 hours

PubMed Research

Research links will be added after PubMed search

Sources

• The Peptides Bible – Neurotrophic peptides section
• Peptide Protocols Master Bible – Neurological rehabilitation protocols
• Auer et al., J Neural Transm — stroke and Cerebrolysin research

#neuroprotection #neurogenesis #dementia #BDNF #NGF #cognitive #stroke #TBI #Cerebrolysin #peptide